HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul S Donnelly Selected Research

alanyltyrosine

12/2020Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model.
1/2020Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer.
10/2019A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention.
8/2015Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul S Donnelly Research Topics

Disease

35Neoplasms (Cancer)
12/2021 - 02/2005
24Alzheimer Disease (Alzheimer's Disease)
09/2021 - 04/2007
12Neurodegenerative Diseases (Neurodegenerative Disease)
04/2019 - 04/2007
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 12/2011
6Prostatic Neoplasms (Prostate Cancer)
01/2021 - 07/2013
5Amyloid Plaque
09/2021 - 03/2015
4Parkinson Disease (Parkinson's Disease)
11/2018 - 01/2012
3Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021 - 01/2019
3Inflammation (Inflammations)
09/2019 - 01/2017
3Neuroblastoma
04/2019 - 02/2011
3Stroke (Strokes)
10/2018 - 01/2012
3Hypoxia (Hypoxemia)
10/2015 - 05/2008
2Fibrosis (Cirrhosis)
01/2022 - 01/2021
2Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 12/2021
2Neuroinflammatory Diseases
01/2018 - 01/2013
2Ischemia
01/2017 - 12/2016
2Bacterial Infections (Bacterial Infection)
10/2015 - 12/2014
2Cognitive Dysfunction
02/2011 - 01/2009
1Cicatrix (Scar)
01/2022
1Lung Neoplasms (Lung Cancer)
12/2021
1Disease Progression
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Lymphoma (Lymphomas)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
11/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2019
1Tauopathies
11/2018
1Frontotemporal Dementia (Semantic Dementia)
11/2018
1Body Weight (Weight, Body)
11/2018

Drug/Important Bio-Agent (IBA)

22CopperIBA
01/2021 - 04/2007
14LigandsIBA
09/2021 - 02/2010
10Amyloid (Amyloid Fibrils)IBA
09/2021 - 03/2011
10Peptides (Polypeptides)IBA
01/2021 - 02/2009
9Radioisotopes (Radionuclides)IBA
01/2021 - 02/2011
9MetalsIBA
11/2018 - 01/2008
9Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2011
7RheniumIBA
09/2021 - 02/2011
7copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
04/2019 - 02/2011
6ThiosemicarbazonesIBA
01/2017 - 02/2005
5AntigensIBA
01/2021 - 10/2019
5ZincIBA
10/2015 - 02/2005
5Amyloid beta-PeptidesIBA
08/2010 - 02/2008
4AminesIBA
09/2021 - 10/2011
4Zirconium-89IBA
01/2021 - 09/2016
4Gallium-68IBA
01/2021 - 10/2011
4Pharmaceutical PreparationsIBA
01/2021 - 01/2016
4alanyltyrosineIBA
12/2020 - 08/2015
4Copper-64IBA
10/2019 - 08/2010
4RadiopharmaceuticalsIBA
10/2019 - 08/2010
4Coordination ComplexesIBA
10/2014 - 11/2009
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 01/2019
3Chelating AgentsIBA
11/2020 - 10/2011
3Trace Elements (Biometals)IBA
01/2018 - 01/2014
3Carboxylic AcidsIBA
03/2017 - 02/2010
3Superoxide Dismutase-1IBA
01/2017 - 06/2014
3IonophoresIBA
09/2015 - 03/2011
3IonsIBA
10/2011 - 02/2008
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 02/2010
2Cisplatin (Platino)FDA LinkGeneric
12/2021 - 12/2021
2perrhenate (rhenium oxide)IBA
09/2021 - 08/2016
2ErbB Receptors (EGF Receptor)IBA
07/2021 - 01/2008
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021 - 12/2020
2Deferoxamine (Desferal)FDA LinkGeneric
01/2021 - 10/2020
2squaramideIBA
01/2021 - 10/2020
2Peptide Receptors (Peptide Receptor)IBA
12/2020 - 01/2019
2carbeneIBA
04/2020 - 02/2017
2Peroxynitrous Acid (Peroxynitrite)IBA
11/2018 - 12/2011
2Technetium (Technetium 99m)IBA
08/2017 - 10/2015
2cyclic arginine-glycine-aspartic acid peptideIBA
08/2017 - 10/2011
2StilbenesIBA
03/2015 - 08/2010
1GadoliniumIBA
01/2022
1AmidesIBA
09/2021
1Sulfhydryl Compounds (Thiols)IBA
09/2021
1AntibodiesIBA
07/2021
1Peptide Hormones (Polypeptide Hormones)IBA
01/2021
1Octreotide (Sandostatin)FDA LinkGeneric
01/2021
1CollagenIBA
01/2021
1CuATSMIBA
01/2021
1AcidsIBA
12/2020
1Monoclonal AntibodiesIBA
11/2020
1Iodine-124IBA
11/2020
1Immunoconjugates (Immunoconjugate)IBA
11/2020
1CarboxypeptidasesIBA
10/2020
1Serum AlbuminIBA
01/2020
1Copper-67IBA
10/2019
1Glutamic Acid (Glutamate)FDA Link
10/2019
1Lysine (L-Lysine)FDA Link
10/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2019
1Biological ProductsIBA
04/2019
1PolyaminesIBA
04/2019
1EthaneIBA
04/2019
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2019
164Cu-SARTATEIBA
01/2019
1Bispecific AntibodiesIBA
01/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2018
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2018

Therapy/Procedure

18Therapeutics
07/2021 - 02/2008
3Drug Therapy (Chemotherapy)
12/2021 - 11/2020
3Precision Medicine
01/2020 - 01/2017
1Intravenous Administration
01/2020